Patient characteristics
| Characteristics . | n (%) . |
|---|---|
| No. of transplants | 944 |
| No. of patients | 874 |
| No. of transplants per patient | |
| 1 | 807 |
| 2 | 64 |
| 3 | 3 |
| Median age (range) at first transplant, y | 3.11 (0.04-17.73) |
| Recipient’s sex | |
| Male | 534 (61.10) |
| Diagnoses | |
| Acute leukemia | 206 (23.57) |
| Acute lymphoblastic leukemia | 119 |
| Acute myeloid leukemia | 82 |
| Mixed lineage leukemia | 2 |
| Acute promyelocytic leukemia | 1 |
| CML in blast crisis | 1 |
| Other malignant hematological diseases | 58 (6.64) |
| Juvenile myelomonocytic leukemia | 23 |
| Myelodysplastic syndrome | 21 |
| Chronic myeloid leukemia | 4 |
| Myeloproliferative disorder | 1 |
| Lymphoma | 8 |
| Nonfocal histiocytic sarcoma | 1 |
| Primary immune deficiencies | 355 (40.62) |
| SCID | 137 |
| Non-SCID | 219 |
| Histiocytic disease | 67 (7.67) |
| Metabolic disease | 72 (8.24) |
| MPS I-II-VI | 32 |
| Osteopetrosis | 19 |
| ALD | 10 |
| Alpha-mannosidosis | 5 |
| Others | 6 |
| Autoimmunity disorders | 7 (0.80) |
| Aplastic anemias | 75 (8.58) |
| Acquired aplastic anemia | 32 |
| BM failure syndromes | 43 |
| Fanconi anemia | 17 |
| Severe congenital neutropenia | 9 |
| Dyskeratosis congenita | 2 |
| Diamond-Blackfan anemia | 2 |
| Congenital amegakaryocytic thrombocytopenia | 2 |
| Shwachman-Diamond syndrome | 1 |
| Paroxysmal nocturnal hemoglobinuria | 1 |
| Congenital BM failure (other/unspecified) | 10 |
| Hemoglobinopathies | 9 (1.03) |
| Glanzmann thrombasthenia | 6 (0.69) |
| Gastroenterology | 19 (2.17) |
| Characteristics . | n (%) . |
|---|---|
| No. of transplants | 944 |
| No. of patients | 874 |
| No. of transplants per patient | |
| 1 | 807 |
| 2 | 64 |
| 3 | 3 |
| Median age (range) at first transplant, y | 3.11 (0.04-17.73) |
| Recipient’s sex | |
| Male | 534 (61.10) |
| Diagnoses | |
| Acute leukemia | 206 (23.57) |
| Acute lymphoblastic leukemia | 119 |
| Acute myeloid leukemia | 82 |
| Mixed lineage leukemia | 2 |
| Acute promyelocytic leukemia | 1 |
| CML in blast crisis | 1 |
| Other malignant hematological diseases | 58 (6.64) |
| Juvenile myelomonocytic leukemia | 23 |
| Myelodysplastic syndrome | 21 |
| Chronic myeloid leukemia | 4 |
| Myeloproliferative disorder | 1 |
| Lymphoma | 8 |
| Nonfocal histiocytic sarcoma | 1 |
| Primary immune deficiencies | 355 (40.62) |
| SCID | 137 |
| Non-SCID | 219 |
| Histiocytic disease | 67 (7.67) |
| Metabolic disease | 72 (8.24) |
| MPS I-II-VI | 32 |
| Osteopetrosis | 19 |
| ALD | 10 |
| Alpha-mannosidosis | 5 |
| Others | 6 |
| Autoimmunity disorders | 7 (0.80) |
| Aplastic anemias | 75 (8.58) |
| Acquired aplastic anemia | 32 |
| BM failure syndromes | 43 |
| Fanconi anemia | 17 |
| Severe congenital neutropenia | 9 |
| Dyskeratosis congenita | 2 |
| Diamond-Blackfan anemia | 2 |
| Congenital amegakaryocytic thrombocytopenia | 2 |
| Shwachman-Diamond syndrome | 1 |
| Paroxysmal nocturnal hemoglobinuria | 1 |
| Congenital BM failure (other/unspecified) | 10 |
| Hemoglobinopathies | 9 (1.03) |
| Glanzmann thrombasthenia | 6 (0.69) |
| Gastroenterology | 19 (2.17) |
ALD, adrenoleukodystrophy; BM, bone marrow; MPS, mucopolysaccharidosis; SCID, severe combined immunodeficiency.